uniQure (QURE) Gross Margin Growth (1y) (2022 - 2026)

uniQure (QURE) Gross Margin Growth (1y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Oculis Holding AG 66,140.12 Bn 66,139.83 Bn - -
2 Nanobiotix 1,912.79 Bn 1,912.73 Bn - -
3 Akari Therapeutics 1,022.34 Bn 1,022.34 Bn - -
4 BeOne Medicines 472.60 Bn 467.81 Bn 1.35 Bn 372.00
5 Vertex Pharmaceuticals 122.34 Bn 115.09 Bn 2.59 Bn -5.00
6 Regeneron Pharmaceuticals 70.14 Bn 61.39 Bn 3.31 Bn -165.00
7 Belite Bio 62.79 Bn 62.79 Bn - -
8 Argenx Se 56.19 Bn 51.00 Bn 1.41 Bn 236.00
9 Alnylam Pharmaceuticals 37.50 Bn 34.49 Bn 959.66 Mn -597.00
10 uniQure 2.44 Bn 2.44 Bn 3.34 Mn 642.00

Historic Data

Download Data
DateValue
Mar 31, 2026 642.00
Dec 31, 2025 30,653.00
Sep 30, 2025 2,235.00
Jun 30, 2025 -1,036.00
Mar 31, 2025 9,439.00
Dec 31, 2024 -38,503.00
Sep 30, 2024 3,840.00
Jun 30, 2024 5,372.00
Mar 31, 2024 -6,124.00
Dec 31, 2023 7,026.00
Sep 30, 2023 -1,208.00
Jun 30, 2023 11,158.00
Dec 31, 2022 354.00
Sep 30, 2022 -5,942.00
Jun 30, 2022 -16,241.00